News and Announcements
EDITORIAL
The current trends in nuclear medicine and radiotherapy
Junjie Wang†*
Show Less
1
Department of Radiation Oncology, Peking University Third Hospital, Beijing,
China
Submitted: 11 August 2023 | Published: 1 September 2023
© 2023 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
References
- Duan H, Iagaru A, Aparici CM, 2022, Radiotheranostics-precision medicine in nuclear medicine and molecular imaging. Nanotheranostics, 6: 103–117. https://doi.org/10.7150/ntno.64141
- Ahn BC, 2017, Nuclear medicine in the era of precision medicine. Nucl Med Mol Imaging, 51: 99–100. https://doi.org/10.1007/s13139-017-0478-5
- Solnes LB, Werner RA, Jones KM, et al., 2020, Theranostics: Leveraging molecular imaging and therapy to impact patient management and secure the future of nuclear medicine. J Nucl Med, 61: 311–318. https://doi.org/10.2967/jnumed.118.220665
- Annunziata S, Treglia G, 2023, Editorial: Radiomics and artificial intelligence in radiology and nuclear medicine. Front Med (Lausanne), 10: 1216434. https://doi.org/10.3389/fmed.2023.1216434
- Jensen AD, 2020, Particle therapy: Protons and heavy ions. Adv Otorhinolaryngol, 84: 87–105. https://doi.org/10.1159/000457929
- Obrador E, Salvador R, Villaescusa JI, et al., 2020, Radioprotection and radiomitigation: From the bench to clinical practice. Biomedicines, 8: 461. https://doi.org/10.3390/biomedicines8110461
- Zhao Y, Hao L, Zhang X, et al., 2022, A novel strategy in electromagnetic wave absorbing and shielding materials design: Multi-responsive field effect. Small Sci, 2: 2100077. https://doi.org/10.1002/smsc.202100077
Conflict of interest
The author declares no conflicts of interest.